The CXCL10/CXCR3 axis regulates Th1 cell differentiation and migration in experimental autoimmune prostatitis through the PI3K/AKT pathway
Andrology · 2024
DOI: 10.1111/andr.13571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Andrology, 2024. Verfasst von Shao-Yu Yue und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, the First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Receptors, CXCR3, Proto-Oncogene Proteins c-akt, Chemokine CXCL10, Th1 Cells. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Fund of China, Anhui Natural Science Foundation, Sanming Project of Medicine in Shenzhen Nanshan.
Abstract (Originalsprache)
Objective
To investigate the mechanism of the CXCL10/CXCR3 axis regulating Th1 cell differentiation and migration through the PI3K/AKT pathway in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Methods
Experimental autoimmune prostatitis (EAP) model, a well‐described and validated animal model of CP/CPPS, was used in our study. After treatment with CXCL10, the severity of EAP and Th1 cell proportion were respectively measured by HE stains, immunohistochemistry, and flow cytometry. Then, the protein expression of the PI3K/AKT pathway in CXCL10/CXCR3‐regulated Th1 cell differentiation and migration was evaluated by western blotting. Additionally, by the CXCR3 antagonist AMG487 and the PI3K inhibitor LY294002 applications, the effects of CXCL10/CXCR3 through PI3K/AKT pathway on the Th1 cell differentiation and migration were further assessed.
Results
The EAP model was successfully built. CXCL10 increased the proportion of Th1 cells in EAP mice, accompanied by upregulation of the PI3K/AKT pathway. Additionally, the PI3K/AKT pathway was found to be involved in CXCL10/CXCR3 axis‐mediated Th1 cell differentiation and migration.
Conclusions
Our investigations indicate that the CXCL10/CXCR3 axis regulates Th1 cell differentiation and migration in EAP through the PI3K/AKT pathway, which provides a new perspective on the immunological mechanisms of CP/CPPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, the First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui, China.
- Institute of Urology, Anhui Medical University, Hefei, Anhui, China.
- Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China.
- Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Urology, Southern University of Science and Technology Hospital, Shenzhen, China.
ORCID-Profile: Shao-Yu Yue, Jialin Meng, Chao-Zhao Liang
Förderung
- National Natural Science Fund of China
- Anhui Natural Science Foundation
- Sanming Project of Medicine in Shenzhen Nanshan
Zitieren
APA
Yue, S. Y., Niu, D., Ma, W. M., Guan, Y., Liu, Q. S., Wang, X. B., Xiao, Y. Z., Meng, J., Ding, K., Zhang, L., Du, H. X., & Liang, C. Z. (2024). The CXCL10/CXCR3 axis regulates Th1 cell differentiation and migration in experimental autoimmune prostatitis through the PI3K/AKT pathway. Andrology. https://doi.org/10.1111/andr.13571
Vancouver
Yue SY, Niu D, Ma WM, Guan Y, Liu QS, Wang XB, et al. The CXCL10/CXCR3 axis regulates Th1 cell differentiation and migration in experimental autoimmune prostatitis through the PI3K/AKT pathway. Andrology. 2024. doi:10.1111/andr.13571
BibTeX
@article{Yue2024,
author = {Yue, Shao-Yu and Niu, Di and Ma, Wen-Ming and Guan, Yu and Liu, Qiu-Shi and Wang, Xiao-Bin and Xiao, Yun-Zheng and Meng, Jialin and Ding, Ke and Zhang, Li and Du, He-Xi and Liang, Chao-Zhao},
title = {The CXCL10/CXCR3 axis regulates Th1 cell differentiation and migration in experimental autoimmune prostatitis through the PI3K/AKT pathway},
journal = {Andrology},
year = {2024},
doi = {10.1111/andr.13571}
}
EUVIMED